‘’The proposal to set up a NLSRC by the DBT is a welcome suggestion’’

Read more

‘’Aim to incentivise higher spending in R&D’’

Read more

‘’Custom duty should be minimised, preferably eliminated’’

Read more

‘’A special focus on R&D funding is required’’

Read more

‘’Encourage R&D activity on clinical research front’’

Read more

‘’GST on drugs must not result in higher tax’’

Read more

‘’We need to sustain significant growth process’’

Read more

February 16-28, 2013

Read more

To poll or not to poll

Read more

Novartis Board of Directors and Dr Daniel Vasella agree to cancel non-compete agreement

Read more